Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10972091rdf:typepubmed:Citationlld:pubmed
pubmed-article:10972091lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10972091lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10972091lifeskim:mentionsumls-concept:C0263338lld:lifeskim
pubmed-article:10972091lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:10972091lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10972091lifeskim:mentionsumls-concept:C0171302lld:lifeskim
pubmed-article:10972091pubmed:issue2lld:pubmed
pubmed-article:10972091pubmed:dateCreated2000-12-11lld:pubmed
pubmed-article:10972091pubmed:abstractTextTo assess the long-term safety and efficacy of the H1-receptor antagonist mizolastine in the symptomatic treatment of chronic urticaria (CU).lld:pubmed
pubmed-article:10972091pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10972091pubmed:languageenglld:pubmed
pubmed-article:10972091pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10972091pubmed:citationSubsetIMlld:pubmed
pubmed-article:10972091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10972091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10972091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10972091pubmed:statusMEDLINElld:pubmed
pubmed-article:10972091pubmed:monthMarlld:pubmed
pubmed-article:10972091pubmed:issn0926-9959lld:pubmed
pubmed-article:10972091pubmed:authorpubmed-author:LeynadierFFlld:pubmed
pubmed-article:10972091pubmed:authorpubmed-author:GiannettiAAlld:pubmed
pubmed-article:10972091pubmed:authorpubmed-author:LoretteGGlld:pubmed
pubmed-article:10972091pubmed:authorpubmed-author:PereiraR SRSlld:pubmed
pubmed-article:10972091pubmed:authorpubmed-author:Murrieta-Agut...lld:pubmed
pubmed-article:10972091pubmed:issnTypePrintlld:pubmed
pubmed-article:10972091pubmed:volume14lld:pubmed
pubmed-article:10972091pubmed:ownerNLMlld:pubmed
pubmed-article:10972091pubmed:authorsCompleteYlld:pubmed
pubmed-article:10972091pubmed:pagination83-90lld:pubmed
pubmed-article:10972091pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:meshHeadingpubmed-meshheading:10972091...lld:pubmed
pubmed-article:10972091pubmed:year2000lld:pubmed
pubmed-article:10972091pubmed:articleTitleOne-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.lld:pubmed
pubmed-article:10972091pubmed:affiliationCHU Trousseau, Chambray Les Tours, France.lld:pubmed
pubmed-article:10972091pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10972091pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10972091pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10972091pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:10972091pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10972091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10972091lld:pubmed